No. Active Graves’ eye disease requires urgent specialist assessment and treatment — teprotumumab, IV corticosteroids, orbital radiotherapy, or surgical intervention — depending on disease severity. Delay in appropriate treatment during active phase can result in permanent vision loss or structural changes. Classical work is supportive only.

Active phase: sleep, autonomic, and general symptom improvement within 2–4 weeks of classical work alongside specialist treatment. Local eye symptoms follow the disease course — typically improving over months with active-phase treatment. Post-active phase: structural changes do not reverse but supportive care continues.

Yes — extensively documented in the literature. Smokers have substantially worse outcomes in Graves’ eye disease regardless of treatment. Smoking cessation is the single highest-impact intervention. Classical treatment can support cessation through autonomic and withdrawal management.

Yes — periocular acupuncture is a recognised technique when performed by an appropriately trained practitioner. In Graves’ eye disease with active inflammation or proptosis, caution is appropriate and some periocular points may be avoided. Distal acupuncture points achieve most of the supportive benefit without local risks. —

Yes — HICAPS-equipped at both Belmont (Perth) and Geraldton (Mid West WA) clinics for on-the-spot rebates with most major Australian health funds.